Year |
Citation |
Score |
2007 |
Marriott LK, McGann-Gramling KR, Hauss-Wegrzyniak B, Sheldahl LC, Shapiro RA, Dorsa DM, Wenk GL. Estrogen replacement regimen and brain infusion of lipopolysaccharide differentially alter steroid receptor expression in the uterus and hypothalamus. Endocrine. 32: 317-28. PMID 18247162 DOI: 10.1007/s12020-008-9038-1 |
0.765 |
|
2007 |
Marriott LK, McGann-Gramling KR, Hauss-Wegrzyniak B, Sheldahl LC, Shapiro RA, Dorsa DM, Wenk GL. Brain infusion of lipopolysaccharide increases uterine growth as a function of estrogen replacement regimen: suppression of uterine estrogen receptor-alpha by constant, but not pulsed, estrogen replacement. Endocrinology. 148: 232-40. PMID 17023524 DOI: 10.1210/en.2006-0642 |
0.761 |
|
2004 |
Mohmmad Abdul H, Wenk GL, Gramling M, Hauss-Wegrzyniak B, Butterfield DA. APP and PS-1 mutations induce brain oxidative stress independent of dietary cholesterol: implications for Alzheimer's disease. Neuroscience Letters. 368: 148-50. PMID 15351438 DOI: 10.1016/J.Neulet.2004.06.077 |
0.567 |
|
2004 |
Rosi S, Ramirez-Amaya V, Hauss-Wegrzyniak B, Wenk GL. Chronic brain inflammation leads to a decline in hippocampal NMDA-R1 receptors. Journal of Neuroinflammation. 1: 12. PMID 15285803 DOI: 10.1186/1742-2094-1-12 |
0.743 |
|
2004 |
Wenk GL, McGann-Gramling K, Hauss-Wegrzyniak B. The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation. Neuroscience. 125: 769-76. PMID 15099690 DOI: 10.1016/j.neuroscience.2004.01.050 |
0.627 |
|
2004 |
Wenk GL, McGann-Gramling K, Hauss-Wegrzyniak B, Ronchetti D, Maucci R, Rosi S, Gasparini L, Ongini E. Attenuation of chronic neuroinflammation by a nitric oxide-releasing derivative of the antioxidant ferulic acid. Journal of Neurochemistry. 89: 484-93. PMID 15056291 DOI: 10.1111/J.1471-4159.2004.02359.X |
0.716 |
|
2004 |
Ongini E, McGann-Gramling K, Hauss-Wegrzyniak B, Ronchetti D, Maucci R, Rosi S, Gasparini L, Wenk GL. P4-214 A nitric oxide-releasing derivative of the antioxidant ferulic acid, NCX 2057, attenuates chronic neuroinflammation in rat Neurobiology of Aging. 25: S536. DOI: 10.1016/S0197-4580(04)81772-X |
0.7 |
|
2004 |
He T, Chen K, Reiman EM, Hicks C, Trouard T, Galons J, Hauss-Wegrzyniak B, Stevenson GD, Valla J, Wenk GL, Alexander GE. P2-192 The computation of mannitol-induced changes in mouse brain volume using sequential MRI and an iterative principal component analysis Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80938-2 |
0.547 |
|
2004 |
Wenk GL, McGann-Gramling KR, Hauss-Wegrzyniak B, Marriott LK. O3-04-01 Neurobiological consequences of chronic and variable estrogen therapy in the presence of long term neuroinflammation Neurobiology of Aging. 25: S59. DOI: 10.1016/S0197-4580(04)80199-4 |
0.722 |
|
2003 |
Wenk GL, McGann K, Hauss-Wegrzyniak B, Rosi S. The toxicity of tumor necrosis factor-alpha upon cholinergic neurons within the nucleus basalis and the role of norepinephrine in the regulation of inflammation: implications for Alzheimer's disease. Neuroscience. 121: 719-29. PMID 14568031 DOI: 10.1016/S0306-4522(03)00545-1 |
0.71 |
|
2003 |
Rosi S, McGann K, Hauss-Wegrzyniak B, Wenk GL. The influence of brain inflammation upon neuronal adenosine A2B receptors. Journal of Neurochemistry. 86: 220-7. PMID 12807441 DOI: 10.1046/j.1471-4159.2003.01825.x |
0.766 |
|
2002 |
Wenk GL, Rosi S, McGann K, Hauss-Wegrzyniak B. A nitric oxide-donating flurbiprofen derivative reduces neuroinflammation without interacting with galantamine in the rat. European Journal of Pharmacology. 453: 319-24. PMID 12398920 DOI: 10.1016/S0014-2999(02)02387-7 |
0.759 |
|
2002 |
Marriott LK, Hauss-Wegrzyniak B, Benton RS, Vraniak PD, Wenk GL. Long-term estrogen therapy worsens the behavioral and neuropathological consequences of chronic brain inflammation. Behavioral Neuroscience. 116: 902-11. PMID 12369809 DOI: 10.1037//0735-7044.116.5.902 |
0.787 |
|
2002 |
Hauss-Wegrzyniak B, Lynch MA, Vraniak PD, Wenk GL. Chronic brain inflammation results in cell loss in the entorhinal cortex and impaired LTP in perforant path-granule cell synapses. Experimental Neurology. 176: 336-41. PMID 12359175 DOI: 10.1006/exnr.2002.7966 |
0.634 |
|
2002 |
Hauss-Wegrzyniak B, Wenk GL. Beta-amyloid deposition in the brains of rats chronically infused with thiorphan or lipopolysaccharide: the role of ascorbic acid in the vehicle. Neuroscience Letters. 322: 75-8. PMID 11958847 DOI: 10.1016/S0304-3940(02)00087-3 |
0.592 |
|
2000 |
Willard LB, Hauss-Wegrzyniak B, Danysz W, Wenk GL. The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition. Experimental Brain Research. 134: 58-65. PMID 11026726 DOI: 10.1007/s002210000446 |
0.783 |
|
2000 |
Hauss-Wegrzyniak B, Galons JP, Wenk GL. Quantitative volumetric analyses of brain magnetic resonance imaging from rat with chronic neuroinflammation. Experimental Neurology. 165: 347-54. PMID 10993694 DOI: 10.1006/exnr.2000.7469 |
0.63 |
|
2000 |
Wenk GL, McGann K, Mencarelli A, Hauss-Wegrzyniak B, Del Soldato P, Fiorucci S. Mechanisms to prevent the toxicity of chronic neuroinflammation on forebrain cholinergic neurons. European Journal of Pharmacology. 402: 77-85. PMID 10940360 DOI: 10.1016/S0014-2999(00)00523-9 |
0.686 |
|
2000 |
Hauss-Wegrzyniak B, Vraniak PD, Wenk GL. LPS-induced neuroinflammatory effects do not recover with time. Neuroreport. 11: 1759-63. PMID 10852239 DOI: 10.1097/00001756-200006050-00032 |
0.674 |
|
2000 |
Hauss-Wegrzyniak B, Vannucchi MG, Wenk GL. Behavioral and ultrastructural changes induced by chronic neuroinflammation in young rats. Brain Research. 859: 157-66. PMID 10720625 DOI: 10.1016/S0006-8993(00)01999-5 |
0.674 |
|
1999 |
Hauss-Wegrzyniak B, Vraniak P, Wenk GL. The effects of a novel NSAID on chronic neuroinflammation are age dependent. Neurobiology of Aging. 20: 305-13. PMID 10588578 DOI: 10.1016/S0197-4580(99)00028-7 |
0.636 |
|
1999 |
Wenk GL, Hauss-Wegrzyniak B. Altered cholinergic function in the basal forebrain of girls with Rett syndrome. Neuropediatrics. 30: 125-9. PMID 10480206 DOI: 10.1055/s-2007-973476 |
0.568 |
|
1999 |
Willard LB, Hauss-Wegrzyniak B, Wenk GL. Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats. Neuroscience. 88: 193-200. PMID 10051200 DOI: 10.1016/S0306-4522(98)00216-4 |
0.78 |
|
1999 |
Hauss-Wegrzyniak B, Willard LB, Del Soldato P, Pepeu G, Wenk GL. Peripheral administration of novel anti-inflammatories can attenuate the effects of chronic inflammation within the CNS. Brain Research. 815: 36-43. PMID 9974120 DOI: 10.1016/S0006-8993(98)01081-6 |
0.773 |
|
1998 |
Wenk GL, Baker LM, Hauss-Wegrzyniak B, Danysz W, Stoehr JD. Novel glycineB antagonists show neuroprotective activity in vivo. Amino Acids. 14: 223-6. PMID 9871465 DOI: 10.1007/BF01345266 |
0.561 |
|
1998 |
Wenk GL, Baker LM, Stoehr JD, Hauss-Wegrzyniak B, Danysz W. Neuroprotection by novel antagonists at the NMDA receptor channel and glycineB sites. European Journal of Pharmacology. 347: 183-7. PMID 9653879 DOI: 10.1016/S0014-2999(98)00112-5 |
0.579 |
|
1998 |
Hauss-Wegrzyniak B, Lukovic L, Bigaud M, Stoeckel ME. Brain inflammatory response induced by intracerebroventricular infusion of lipopolysaccharide: an immunohistochemical study. Brain Research. 794: 211-24. PMID 9622633 DOI: 10.1016/S0006-8993(98)00227-3 |
0.509 |
|
1998 |
Hauss-Wegrzyniak B, Dobrzanski P, Stoehr JD, Wenk GL. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Research. 780: 294-303. PMID 9507169 DOI: 10.1016/S0006-8993(97)01215-8 |
0.695 |
|
1998 |
Baker L, Hauss-Wegrzyniak B, Wenk G. The effect of a novel NO-NSAID on chronic neuroinflammation Journal of Neuroimmunology. 90: 79. DOI: 10.1016/S0165-5728(98)91653-8 |
0.583 |
|
Show low-probability matches. |